IDSA/SCCM Evaluating New Fever in Adult Patients in the ICU Guideline Summary - Guideline Central
Consensus Recommendations
Document Overview

Evaluating New Fever in Adult Patients in the ICU

Infectious Diseases Society of America

Society of Critical Care Medicine


Publication Date: Oct 12, 2023

Page Last Updated: May 6, 2026


Society of Critical Care Medicine GRADE System


Document Overview

Document Title
Evaluating New Fever in Adult Patients in the ICU
Authoring Societies

Infectious Diseases Society of America

Society of Critical Care Medicine

Document Publication Date
Oct 12, 2023
Page Last Reviewed/Updated
May 6, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
journals.lww.com/ccmjournal/fulltext/2023/11000/society_of_critical_care_medicine_and_the.13.aspx
Source Citation

O’Grady, Naomi P. MD, FCCM, FIDSA1; Alexander, Earnest PharmD, FCCM2; Alhazzani, Waleed MBBS, MSc, FRCPC3; Alshamsi, Fayez MBBS4; Cuellar-Rodriguez, Jennifer MD5; Jefferson, Brian K. DNP, ACNP-BC, FCCM6; Kalil, Andre C. MD, MPH, FCCM, FIDSA7; Pastores, Stephen M. MD, MACP, FCCP, FCCM8; Patel, Robin MD, FIDSA, FRCPC9,10; van Duin, David MD, PhD, FIDSA11; Weber, David J. MD, FIDSA, FSHEA, FRSM, FAST11; Deresinski, Stanley MD, FIDSA12. Society of Critical Care Medicine and the Infectious Diseases Society of America Guidelines for Evaluating New Fever in Adult Patients in the ICU. Critical Care Medicine 51(11):p 1570-1586, November 2023. | DOI: 10.1097/CCM.0000000000006022


Document Scope, Criteria, and Use Cases

Document Objectives

The guidelines panel was able to formulate several recommendations for the evaluation of new fever in a critically ill adult patient, acknowledging that most recommendations were based on weak evidence. This highlights the need for the rapid advancement of research in all aspects of this issue—including better noninvasive methods to measure core body temperature, the use of diagnostic imaging, advances in microbiology including molecular testing, and the use of biomarkers.

Scope
Assessment and Screening, Diagnosis
Diseases/Conditions (MeSH)

D003422 - Critical Care

D005334 - Fever

D016638 - Critical Illness

D007362 - Intensive Care Units

D003422 - Critical Care

D005334 - Fever

D016638 - Critical Illness

D007362 - Intensive Care Units

Keywords
ICU, critically ill, fever, intensive care, intensive care unit
Target Patient Population
Critically ill adult patients in the hospital or ICU presenting with new fever
Target Provider Population
Critical care, infectious diseases, clinical microbiology, organ transplantation, public health, clinical research, and health policy and administration
Inclusion Criteria
Male, Female, Adult, Older Adult
Health Care Settings
Emergency Care, Hospital
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resource
Data Supplement
Number of Source Documents
112
Literature Search End Date
Wednesday, June 29, 2022
Includes peer/external review process?
Yes
Includes public comment process?
No
Methodologist involvement?
Yes
Patient involvement?
No
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
Yes
Grades quality of strength of recommendation?
Yes
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
Yes
Identifies study selection process?
Yes
Identifies study selection criteria?
Yes
Identifies methods used to evaluate and analyze the evidence?
Yes
Identifies key questions addressed by the systematic review?
Yes
Identifies search strategy?
Yes
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.